Accutane(isotretinoin) coverage depends on your specific health insurance and often requires a prior authorization, where your dermatologist must prove you've tried other treatments first.

Accutane (isotretinoin) coverage depends on your specific health insurance plan and often requires a prior authorization, where your dermatologist must prove you've tried other treatments first. Your insurer may prefer or only cover the less expensive generic versions, and you will likely still be responsible for costs like co-pays and lab fees. To confirm coverage and costs, contact your insurance provider and doctor before starting treatment. 

Key considerations for insurance coverage: 

• Prior Authorization:

  Most insurance plans require this process for isotretinoin, where the insurer and your doctor discuss your treatment and approve it.
• Generic vs. Brand-Name:

  Insurers often prefer generic forms of isotretinoin (like Claravis or Myorisan) over the brand-name Accutane.
• Additional Costs:

  Even with insurance, you may have to pay for lab tests, monthly doctor visits, and co-pays.
• Check Before You Start:

  Always verify coverage and potential costs with your insurance company and doctor before beginning the prescription.

What to do if your insurance denies coverage:

• Review the Denial:

  Carefully read the denial letter to understand the specific reason for the decision. 
• Contact Your Insurance:

  Speak with your insurance provider to learn more about the requirements. 
• Appeal the Decision:

  You can appeal the denial by providing additional information or working with your doctor to submit a strong case. 
• Explore Alternatives:

  If Accutane is not covered, discuss alternative acne treatments with your dermatologist. 
• Look for Savings Programs:

  For commercial plans, you might be able to use a manufacturer's savings card to reduce your out-of-pocket costs for Teva's isotretinoin. 

Phamacy Council Election

#PhamacyCouncilElection

All ills of Pharmacy councils are due to syndicate grouping of Yes-Men who preplan #MatchFixMeetings and Resolutions.

Hence, Tips to Voters:

👉Do not vote for all in one group.

- They become Yes-Men to their leader to flout all Rules and Regulations and it may lead to loot funds.

👉 Pick Good People from each group and do not ignore independents.

👉 Keep the elected members answerable to the Regd Pharmacists.

Good wishes

POV: Bhagwan PS

'Profession Vs Job' - Professional standards do not compromise whereas Job standards can be compromised.!

'Profession Vs Job'

Professional standards do not compromise whereas Job standards can be compromised.!

Making M Pharm equally eligible as Pharm D for Clinical Pharmacist post has Compromised the Profession.

Hence #NotAWiseMove.

A post in a Wtsp group:

    "Dear Sir/Madam, In a major relief to MPharm degree holders, the Union government has decided to include MPharm (pharmacy practice) as a sufficient qualification for appointing clinical pharmacists to hospitals. The government clarified its stance in the High Court in response to a batch of writ petitions filed by various MPharm degree holders.

Justice Viju Abraham, who considered the petitions, directed the government to implement the decision within three months. Earlier, the government had excluded MPharm as the eligible qualification for serving as clinical pharmacists in hospitals through an amendment brought to the Pharmacy Practice Regulations Act in 2019. Through this amendment, the government made doctor of pharmacy (Pharm D) the qualification for the post."

PCI committed the same blunder while starting B Pharm keeping D Pharm alive.

Had the D Pharm been closed the Hospital Pharmacy would have been in a strong position by now in health

sector.

This is result of having professionally unqualified people in authority.

Pov: Bhagwan PS

Vision Of The Indian PPR Act by Bhagwan PS

#MyVisionOfTheIndianPPRAct

Pov: Bhagwan PS

Given the persistent failure of institutions and systems to provide fair, deserved opportunities to qualified pharmacists, an exclusive legislation with clear empowerment and accountability has become essential.

The Pharmacy Practice Regulations (PPR) Act is envisioned as the legal and professional backbone for safe, effective, and ethical pharmaceutical care in India. It will authorize pharmacists as direct patient care providers, backed by professional accountability, standard operating procedures, and defined service delivery models—integrating them seamlessly into the healthcare continuum.

Under the PharmaCare Clinical Support System, the Act applies across all professional tiers—D Pharm, B Pharm, M Pharm, and PharmD—with structured, competency-based roles:

1. #DiplomaInPharmacy (D Pharm):

Frontline dispensers and community care providers. Trained in medication handling, prescription verification, OTC guidance, and basic counselling. Accountable for legal dispensing, adverse event reporting, and prescription record maintenance.

2. #BachelorOfPharmacy (B Pharm):

Advanced technical and operational support. Skilled in dosage form optimisation, supply chain integrity, pharmacovigilance, and rational drug use promotion. Authorized to conduct prescription audits, assist in therapeutic substitutions under protocol, and support primary care clinics in medication therapy management.

3. #MasterOfPharmacy (M Pharm – Pharmacy Practice / Clinical / Hospital Pharmacy):

Specialised medication experts in clinical decision support, formulary management, and interprofessional collaboration. Lead quality improvement programs, train juniors, develop evidence-based protocols, and support health technology assessment initiatives.

4. #DoctorOfPharmacy (PharmD):

Apex patient-care pharmacists integrated into clinical teams. Conduct medication histories, identify and resolve drug-related problems, perform therapeutic drug monitoring, and provide evidence-based therapy recommendations. Drive clinical governance, patient safety initiatives, and pharmacare research.

The #PPRAct’s PharmaCare model creates a continuous patient-care chain where each cadre complements the next—ensuring medication use is safe, effective, and cost-efficient. It mandates standardised documentation, ICT-enabled monitoring, and continuous professional development to maintain competence.

Ultimately, the Act positions pharmacists as indispensable members of healthcare teams—bridging the gap between prescription and patient outcomes, reducing medication errors, and improving public health metrics. It shifts pharmacy practice from a supply-driven role to a patient-centred, outcome-oriented healthcare service—securing the pharmacist’s place as a critical partner in India’s healthcare service system.

PCI to integrate pharmacists' database with Healthcare Professional Registry

Gireesh Babu, New Delhi Saturday, November 23, 2024, 08:00 Hrs  [IST]

The Pharmacy Council of India (PCI) has sought all the pharmacists who don't have the ABHA (Ayushman Bharat Health Account) number to attain a number and ensure registration with the DIGI-PHARMed profile with the ABHA number on immediate basis, as part of its efforts to integrate the pharmacists' list with the Healthcare Professional Registry (HPR). The Council is in the process of verification of all registered pharmacists on the DIGI-PHARMed portal in order to integrate pharmacists with the HPR, and asked all the pharmacists to consider certain action points in order to equip the Council for a smooth integration. "All registered pharmacists are requested to verify their DIGI-PHARMed profile with the ABHA Number on immediate basis. The said verification must be completed within the timeline of 45 days from the date of issuance of this circular," said the Council in a communication to all registered pharmacists. "Failing to this, the pharmacist's profile will be disabled for any further usage on the DIGI-PHARMed portal," it added. In case of new registration, pharmacists must ensure to verify their account with the ABHA number at the time of registration and without verification of the profile with this number will be considered as incomplete registration. If the pharmacists don't have the ABHA number, it is directed to create the ABHA number using Aadhar before initiating the process or the registration of DIGI-Pharmed portal. The Council also requested to all the pharmacy institutions as well to check that all the faculty in their institutions are having the ABHA verified profiles and notified that during the Standard Inspection Format (SIF) applications and for further reference, only ABHA verified profiled of faculty will be considered by the Council from 2025-26 academic session, it added. It also directed all pharmacists that they must ensure that the documents uploaded to the portal while registering are authentic and validated. "If the Council discovers at any stage that any documents submitted during the registration process are incorrect, the respective profile of those pharmacists will be blacklisted," said the Council. In case of any inconvenience or technical issues, the pharmacists or the institutions can share the issues over email to the Council or reach out over telephone, it added. Healthcare Professionals Registry is a comprehensive repository of registered and verified different system of medicines (modern medicine, dentistry, Ayurveda, Unani, Siddha, Sowa-Rigpa, Homoeopathy) and nurses practitioners delivering healthcare services across India.  The ABHA number will be used for the purposes of uniquely identifying persons, authenticating them, and threading their health records (only with the informed consent of the patient) across multiple systems and stakeholders The repository is part of the Ayushman Bharat Digital Mission (ABDM), which empowers healthcare professionals to be part of India’s digital health ecosystem through a unique healthcare professional ID. With last mile coverage, people will be able to interact with healthcare practitioners or vice versa. Healthcare professional profile visible in the ABDM ecosystem is verified and authorised to practice medicine in the country. The HPR ensures that healthcare practitioners suitably trained and qualified to practice medicine with competence and ethical conformity are allowed to register with the HPR. Pharmacists are HealthCare Professionals. Lets be worth it. Really!!!,  then why the term ' PharmaCare ' was coined. Pharmacist A HealthCare professional? If so why pharmacy course is not?. Has the Pharmacy education been got included in National Health Education Manual? ok

So many regulatory bodies and governing bodies in pharmacy education: whims of my mind

PCI(Pharmacy Council Of India) and AICTE(All India Council for technical education) are the governing bodies in the pharmacy education , keeping in mind the compounding and dispensing as well as the technical aspects involved in Pharmaceutical Engineering .

Now with the advent of Pharm D course in pharmacy, which is clinically oriented 6 years course in pharmacy and the syllabus is designed such as  first 3 years are same as B.Pharm ( compounding and dispensing oriented) and next 2 years are same as MD Pharmacology (medically and clinically oriented) and 1 year of internship in an attached (minimum- 300 beded) hospital , one may expect MCI (medical council of India) to get into the thick of the things/matters.

As it requires an affiliation with a  hospital( minimum 300 beded), to get approval for an pharmaceutical institute from PCI to conduct the course , one must expect MCI(medical council of India)(Now NMC) also to get involved as a regulatory and governing body.

PCI governs courses like : D.Pharm
                                         B.Pharm
                                        Pharm D and Pharm D(PB)

AICTE governs courses like : B.Pharm( jointly with PCI)
                                              M.Pharm

Now one must expect AICTE,PCI and MCI may jointly govern : Pharm D and Pharm D(PB)

But no, its not a rational thinking on my part. MCI (Now NMC ) will get involve only when the course is a medical one or may be when the professional doctor is dealing with a body part.
So, its fair enough that MCI(NMC) is not involved into these matters.(Really?!!!)

                                             

Pharm D course introduction and D Pharma course closure is Propaganda !!! Is Pharm D and Pharm D(PB) course is approved by UGC?

I don't understand why D. Pharma course is being removed as minimum qualification for registration to practice Pharmacy in India. 

They say due to corruption. (Propaganda)

But I have seen corruption and malpractices happening at higher education level as well. 

1)PhD and PharmD students/interns publishing their names in scientific journals for research articles in which they have not done anything and just paid asked amount to the principal researcher so that their name get added in the research article as co-authors or co-researchers for publishing in scientific journals.

2)illogical sequence of subjects taught at colleges with these newly started courses.

3)Renting of license will continue even on Pharm-D ( doctor of pharmacy) degree.

4)To make minimum qualification for a registered pharmacist to do pharmacy practice in India, Pharm-D degree rather than D.Pharm ie. to replace the state's diploma of pharmacist.

Instead of updating and upgrading the syllabus of D.Pharm, what the policy makers have done is that they have created a new course named Pharm.D/Pharmd(PB) and obvious plan is to make it the minimum qualification for a registered pharmacist to do pharmacy practice in India and produce so called Next Generation and New Age Pharmacist. It's like a RESTART button pressed on.

Why create so much confusion, why malign the integrity of Pharmacy field. They could have retained the D.Pharm course and should have made neccessary changes in the syllabus and duration of D.Pharm, so that the minimum qualification for a registered pharmacist to do pharmacy practice in India remain D.Pharm and no need to replace the state's diploma of pharmacist. 

Just imagine if M.B.B.S course is replaced by some other course which is made minimum qualification for a registered physician to do medical practice in India.

And then they call themselves Pharma Expert or Drug Expert (DRX). What a pity situation ?

Is Pharm D and Pharm D(PB) course is approved by UGC? 

Medical Science vs Pharmaceutical Science (Residential Program Year)

RPY: Residential Program Year

Pharmacy residency is education a pharmacist can pursue beyond the degree required for licensing as a pharmacist (in the United States of America: PharmD). A pharmacy residency program allows for the implementation of skill set and knowledge acquired in pharmacy school through interaction with the public either in a hospital setting or community practice.The program is done over a span of about two years after graduation from pharmacy school and licensure as a pharmacist. Pharmacy residency helps improve the resume of a pharmacist so as to increase chances of obtaining employment outside community practice. A 2022 review suggested that there is sufficient evidence that residency develops key competencies for junior pharmacists

In India, after completing a Pharm.D. (Doctor of Pharmacy) degree, students can pursue residency programs to specialize in clinical pharmacy or related fields, enhancing their expertise and career prospects. These programs, often lasting one to two years, provide advanced training in areas like clinical pharmacy practice, patient care, and drug information. 

Details about Pharm.D. and Residency in India:

• Pharm.D. as a Professional Qualification:

  The Pharm.D. is a professional doctorate recognized by the Pharmacy Council of India (PCI). It signifies expertise in pharmacy practice and allows graduates to become licensed pharmacists. 
• Residency Programs:
• Following the Pharm.D., residency programs offer specialized training in various clinical settings, such as hospitals and clinics. 
• Focus Areas:
• Residency programs can focus on areas like:

  • Clinical Pharmacy: Providing patient-centered care, medication therapy management, and drug information services. 
  • Critical Care: Managing patients in intensive care units, focusing on advanced life support and critical care protocols. 
  • Other Specializations: Opportunities may also exist in areas like oncology, cardiology, and infectious disease, depending on the specific program and institution. 
  • Career Paths:
• Residency training can lead to various career opportunities, including:

  • Clinical Pharmacist Roles: In hospitals and other healthcare settings, directly involved in patient care. 
  • Medical Affairs: Bridging the gap between pharmaceutical companies and healthcare professionals, providing scientific expertise and support. 
  • Research: Participating in clinical trials and research activities.   
  •  Duration:Residency programs typically last one to two years, depending on the specialization and institution. 
• Benefits:Residency programs offer valuable practical experience, enhance clinical skills, and improve career prospects for Pharm.D. graduates. 

Residency Medicine

Residency or postgraduate training is a stage of graduate medical education. It refers to a qualified physician (one who holds the degree of MD, DO, MBBS/MBChB), veterinarian (DVM/VMD, BVSc/BVMS), dentist (DDS or DMD), podiatrist (DPM), optometrist (OD), pharmacist (PharmD), or Medical Laboratory Scientist (Doctor of Medical Laboratory Science) who practices medicine or surgery, veterinary medicine, dentistry, optometry, podiatry, clinical pharmacy, or Clinical Laboratory Science, respectively, usually in a hospital or clinic, under the direct or indirect supervision of a senior medical clinician registered in that specialty such as an attending physician or consultant.

The term residency is named as such due to resident physicians (resident doctors) of the 19th century residing at the dormitories of the hospital in which they received training.^[1]

In many jurisdictions, successful completion of such training is a requirement in order to obtain an unrestricted license to practice medicine, and in particular a license to practice a chosen specialty. In the meantime, they practice "on" the license of their supervising physician. An individual engaged in such training may be referred to as a resident physician, house officer, registrar or trainee depending on the jurisdiction. Residency training may be followed by fellowship or sub-specialty training.^[2]

Whereas medical school teaches physicians a broad range of medical knowledge, basic clinical skills, and supervised experience practicing medicine in a variety of fields, medical residency gives in-depth training within a specific branch of medicine.

In India, medical residency, also known as postgraduate training, typically lasts for 3 years after completing the MBBS degree. It's a period of intensive clinical training in a chosen specialty, preparing doctors for independent practice. The residency program is structured with academic coursework, clinical rotations in various departments, and research components, culminating in an MD or MS degree (depending on the specialty). 

Key aspects of medical residency in India:

Duration: Generally 3 years for most specialties, but can vary. 


Eligibility: Requires completion of MBBS and passing the NEET-PG exam. 


Structure: Includes clinical rotations, academic learning (case discussions, seminars, etc.), and research. 


Focus: Hands-on clinical experience and development of practical skills under supervision. 


Outcome: Leads to an MD or MS degree in the chosen specialty and prepares doctors for independent practice. 


Supervision: Residents work under the guidance of attending physicians and consultants. 


Workload: Residents typically work long hours, including nights, weekends, and holidays. 

Is Pharm D and Pharm D(PB) course is approved by UGC?

University Grants Commission (UGC) is a statutory body under Department of Higher Education, Ministry of Education, Government of India. It was set up in accordance to the UGC Act 1956 and is charged with coordination, determination and maintenance of standards of higher education in India. It provides recognition to universities in India, and disbursements of funds to such recognized universities and colleges. The UGC headquarters are in New Delhi, and it has six regional centres in Pune, Bhopal, Kolkata, Hyderabad, Guwahati and Bengaluru. A proposal to replace it with another new regulatory body called HECI is under consideration by the Government of India. The UGC provides doctoral scholarships to all those who clear JRF in the National Eligibility Test. On an average, each year ₹725 crore (US$86 million) is spent on doctoral and post-doctoral fellowships by the commission.

Pharmacists are Healthcare Professionals or Pharmacare Professionals?

Pharmacists are HealthCare Professionals.

Lets be worth it.

Really!!!,  then why the term ' PharmaCare ' was coined.

Pharmacist A HealthCare professional? If so why pharmacy course is not?. Has the Pharmacy education been got included in National Health Education Manual?

Someone kindled me to define and explain who is Healthcare professional? Where does the Pharmacist fit in?

Healthcare Professional.

Someone kindled me to define and explain who is Healthcare professional? Where does the Pharmacist fit in?

Not an easy question in light of Second question.

Any professional who serves the humans to safeguard his / her health and serves to mitigate the suffering and assists and supports the patient to be as comfortable as possible and treats him directly and fecilitates treatment could be called healthcare professional or Health Worker. All put together could be called a Medical Team

[This is my own extempore definition, I am subject to correction]

Now coming to second question,

Where does the Pharmacist fit in to be called Healthcare professional?

Excluding Pharm D Pharmacists, considering prevailing scenario and practice in India  the Pharmacist looks like a supporter external to the Treatment team  only to dispense what is advised. 

Unless the Pharmacists update themselves  or Course content is updated to familiarise the students on healthcare practices in preventive and curative services Pharmacists of India may not gain the Healthcare Professional tag.

#PCI, #IPA, #APTI,

POV :Bhagwan PS

Pharmacists are HealthCare Professionals.

Lets be worth it.

Really!!!,  then why the term ' PharmaCare ' was coined.

Pharmacist A HealthCare professional? If so why pharmacy course is not?. Has the Pharmacy education been got included in National Health Education Manual?

A different POV : Pharmacists have failed to impress professionally and leave professional footprints in Healthcare Sector

A different POV : Pharmacists have failed to impress professionally and leave professional footprints in Healthcare Sector . Therefore requirement of a new course like Pharm D / Pharma D (PB), which will produce professionals called Pharmacist and Pharmacotherapist. 

Is it true ? Really!!! 

Pharmacists are HealthCare Professionals.

Lets be worth it.

Really!!!,  then why the term ' PharmaCare ' was coined.

Pharmacist A HealthCare professional? If so why pharmacy course is not?. Has the Pharmacy education been got included in National Health Education Manual?

Digital Prescriptions are the solution

Handwritten prescriptions in India often pose significant risks due to their potential for misinterpretation. The diverse linguistic landscape of India, with multiple languages and scripts, adds to the complexity of deciphering these prescriptions accurately. Common issues include illegible handwriting, which can lead to confusion between drugs with similar names or incorrect dosing instructions. This is particularly problematic given the wide range of medications available and the critical importance of precise dosages.

Moreover, handwritten prescriptions sometimes lack essential information such as patient history, allergies, or specific instructions for drug administration. In a healthcare environment where pharmacists play a key role in the safe dispensing of medications, these omissions can lead to serious health risks.

The situation calls for a more robust system, possibly incorporating digital prescriptions, which can ensure clarity, accuracy, and traceability. Standardizing prescription formats and embracing electronic health records could greatly mitigate the risks associated with handwritten prescriptions, leading to safer and more effective patient care in the Indian context.

Q-commerce is here to stay, retailers must upgrade themselves’, says CEO of Retailers Association of India

Q-commerce is here to stay, retailers must upgrade themselves’, says CEO of Retailers Association of India

On September 26, Madras High Court lawyer K Narasimhan alleged in his complaint to the DPIIT that e-commerce platform Flipkart is offering discounts at product level for select sellers and creating a non-competitive environment.

By  IMRAN FAZAL| Sep 27, 2024 8:44 AM

‘Q-commerce is here to stay, retailers must upgrade themselves’, says CEO of Retailers Association of India

The Department for Promotion of Industry and Internal Trade (DPIIT) has referred a complaint against quick commerce companies to the CCI for further investigation.

Multiple retail trade associations and federations have written to the Indian government, expressing concerns that the growth of Q-commerce platforms is hurting their retail businesses. The Retailers Association of India (RAI) believes that instead of complaining about the rise of Q-commerce and e-commerce platforms, retailers should focus on upgrading themselves.

It's worth noting that several FMCG companies have reported strong double-digit growth in online sales through quick-commerce. According to a RedSeer report, the Q-commerce market is expected to reach $5.5 billion by 2025. The contribution of quick-commerce platforms to the online grocery market is projected to increase from 10% to 45% in the coming years. In 2023, the gross merchandise value (GMV) of quick commerce in India reached $2.3 billion, showing a growth of over 70% compared to the previous year.

RELATED STORIES

‘Q-commerce is here to stay, retailers must upgrade themselves’, says CEO of Retailers Association of India

On the sidelines of the Retail Technology Conclave, ReTechCon 2024, Kumar Rajagopalan, CEO of the Retailers Association of India (RAI), spoke to Storyboard18 about the ongoing Q-commerce vs. Retailers conflict, which has now reached the Competition Commission of India (CCI).

Addressing the allegations of unfair trade practices by Q-commerce and e-commerce platforms, Rajagopalan stated, “When it comes to unfair trade practices and allegations by retailers, we need to wait and see. The government has a mechanism to address such issues.”

Rajagopalan added, “As far as Q-commerce platforms are concerned, they are here to stay because customers are getting something they've always wanted. At RAI, we believe in creating a level playing field for all retailers, and the Indian government has already launched the Open Network for Digital Commerce (ONDC), which will likely incorporate hyper-local and fast-commerce capabilities.”

He went on to say, “We are waiting for ONDC to improve further, and RAI is actively working with them. I believe that when your trusted local retailer can provide the product you want, whether online or offline, at the desired speed, small retailers will naturally thrive.”

Rajagopalan emphasized, “Our goal is to help small retailers improve their operations. As the Retailers Association, we don’t believe in halting new or innovative businesses, but we aim to ensure everyone has a level playing field.”

Recently, All India Consumer Products Distributors Federation (AICPDF), which claims to represent about 800,000 entities, expressed concerns over the rapid expansion of quick commerce platforms. They allege that these platforms create an uneven playing field, negatively impacting small retailers.

The AICPDF submitted a complaint to the Ministry of Commerce and Industry, raising concerns about anti-competitive practices by quick commerce companies and calling for an investigation.

When asked about RAI's stance on this issue, Rajagopalan said, “The debate over whether retailers should be available both online and offline is now irrelevant. Customers are shopping both ways. Any retailer worth their salt must be available online and offline, which is why I support ONDC. You can’t do anything that goes against customer interests—it will backfire.”

He added, “The key is to enable everyone to do business for the customer. However, if someone is engaging in deep discounting or loss leadership practices that are anti-competitive, these should be addressed, and it’s the government’s responsibility to ensure such practices are stopped.”

“At RAI, we always emphasize a level playing field. No one should take undue advantage of the situation with unfair trade practices. At the same time, businesses should not expect things to be the same as they were a decade ago—COVID has changed all of us as consumers. Retailers must adopt new methods to upgrade themselves.”

The Department for Promotion of Industry and Internal Trade (DPIIT) has referred a complaint against quick commerce companies to the CCI for further investigation.

Moreover, Confederation of All India Traders (CAIT) has urged the government to suspend the 'festival sales' events of Amazon and Flipkart, as they will further harm domestic traders through the continued use of anti-competitive practices.

On September 26, Madras High Court lawyer K Narasimhan alleged in his complaint to the DPIIT that e-commerce platform Flipkart is offering discounts at product level for select sellers and creating a non-competitive environment. The letter was sent to the Department for Promotion of Industry and Internal Trade Secretary Amardeep Singh Bhalla.

CBI raids PCI President Montu Patel in bribery probe

🔎 On July 3, 2025, the CBI raided the Ahmedabad and Gandhinagar homes of PCI President Montu Kumar Patel over alleged bribery and college approval irregularities . 

💸 An FIR alleges Dr. Patel accepted bribes to approve underqualified pharmacy colleges and bypass proper inspections . 

📺 Physical inspections were scrapped in favor of quick 8‑minute online audits in 2023–24, paving the way for potential corruption .

 🏫 Investigators found “phantom colleges” in UP, MP, Gujarat & Rajasthan approved despite dilapidated infrastructure .

 🕴️ A senior CBI officer noted that “college recognitions were being sold for money under Patel’s tenure” . 

🤐 The probe uncovered fake records, back‑dated approvals, GPSC portal manipulation, and electoral sway tactics . 🧠 The investigation follows a Supreme Court critique in May over PCI’s “arbitrary” decisions—spotlighting deep governance issues . 

🧾 The CBI will likely expand the probe to cover key states like Maharashtra, targeting systemic faults . 

⚠️ Dr. Patel, elected in April 2022, hasn’t been arrested yet; however, the evidence seized is described as “substantial” . 🏛️ With accreditation credibility at stake, experts now call for a full overhaul of PCI’s college recognition and inspection system . 

What’s your thoughts on this?

Sources : Harsh Y

#PharmacyEducation #PharmaRegulation #PharmacyCouncilOfIndia #PharmaGovernance #PharmaLeadership #PharmacyColleges #PharmaIndia #EducationStandards